Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06250569
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-09
First Post:
2024-01-26
Brief Title:
Adenomyosis in Fertile Women in MUSA Criteria
Sponsor:
Assiut University
Organization:
Assiut University
Study Overview
Official Title:
Application of the Revised Morphological Uterus Sonographic Assessment MUSA Criteria to Diagnose Adenomyosis in Fertile Women
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
1 To estimate the prevalence of adenomyosis in fertile women aged 18-30 years using the revised MUSA ultrasound criteria
2 To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population
2 To evaluate clinical risk factors that are associated with adenomyosis diagnosis in this population
Detailed Description:
Adenomyosis is a benign condition characterized by the presence endometrial glands and stroma within the myometrium Its prevalence varies from 5-70 The definitive diagnosis of adenomyosis is based mainly on histological assessment of hysterectomy specimens This led to a concept that adenomyosis affects only parous women between 35-50 years who complain of dysmenorrhea and heavy menstrual bleeding Magnetic Resonance Imaging MRI can detect adenomyosis with a sensitivity of 80 Transvaginal ultrasound using the revised Morphological Uterus Sonographic Assessment MUSA criteria can detect adenomyosis non-invasively at a lower cost Such advancements in imaging techniques allow studying the prevalence of the disease in wider range of population including young women
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None